Literature DB >> 33639311

Effects of recipient age, heparin release and allogeneic bone marrow-derived stromal cells on vascular graft remodeling.

Richard Johnson1, Michael Rafuse1, Prakash Parthiban Selvakumar1, Wei Tan2.   

Abstract

Small-caliber vascular grafts are used in a wide range of clinical conditions. However, there remains a substantial unfulfilled need for readily-available, synthetic vascular grafts with high long-term patency rate. To fulfill the translational goal for bioengineered vascular grafts, important considerations for the pre-clinical evaluation include the graft design, cell incorporation and selection of an animal model. To assess the three factors, we used vascular grafts consisting of core/shell-structured microfibers of polycaprolactone/gelatin with a thin polycaprolactone overlay. The respective influences of the heparin release mode, animal age, and allogeneic bone marrow-derived stromal cells (MSCs) seeded in the lumen on the graft remodeling were assessed after four-and-half-month implantation on an interposition graft of abdominal aorta model. Except two rats dying from graft-unrelated issues, all other rats (18 out of 20) showed good graft patency upon explantation. The cell phenotype, matrix content and structure in the neotissues around the graft, as well as the flow perfusion through the graft were examined. More grafts in the aged rats showed local narrowing and flow incongruence than the other grafts in young adult rats. Compared to acellular grafts, cellular grafts showed efficient recruitment of vascular cells to form more organized structures with elastin in the vascular wall. Endothelialization and α-smooth muscle actin-positive cells were shown in all four types of vascular grafts. This study revealed the significant effects of MSC and recipient age but not heparin release pattern on graft remodeling. STATEMENT OF SIGNIFICANCE: The vascular graft is a mainstream of surgical intervention to treat vascular diseases. Currently, vascular grafts, particularly small-diameter ones, still show high failure rates. This study has evaluated the respective impacts of heparin release pattern, allogeneic bone marrow-derived stromal cell seeding, and recipient age on the long-term remodeling of vascular grafts. There is a dearth of literature which considers the recipient age as an influencing factor for vascular grafting. However, adults particularly elderly constitute the majority of vascular graft recipients in the "real" clinical environment. While juvenile animals were widely used for graft evaluations, this study involved adult animals. The study outcomes provided important implications regarding graft designs and evaluation approaches.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33639311      PMCID: PMC8189838          DOI: 10.1016/j.actbio.2021.02.028

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  52 in total

Review 1.  Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.

Authors:  Jacques Galipeau; Luc Sensébé
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

Review 2.  Age associated communication between cells and matrix: a potential impact on stem cell-based tissue regeneration strategies.

Authors:  Kevin Lynch; Ming Pei
Journal:  Organogenesis       Date:  2014       Impact factor: 2.500

3.  Performance of marrow stromal cell-seeded small-caliber multilayered vascular graft in a senescent sheep model.

Authors:  Krishna Madhavan; Winston Elliot; Yan Tan; Eric Monnet; Wei Tan
Journal:  Biomed Mater       Date:  2018-06-14       Impact factor: 3.715

4.  Animal Models in Tissue Engineering. Part I.

Authors:  Jorge A Piedrahita; J Koudy Williams
Journal:  Tissue Eng Part C Methods       Date:  2017-11       Impact factor: 3.056

5.  Cell-type specificity of β-actin expression and its clinicopathological correlation in gastric adenocarcinoma.

Authors:  Shafqat A Khan; Monica Tyagi; Ajit K Sharma; Savio G Barreto; Bhawna Sirohi; Mukta Ramadwar; Shailesh V Shrikhande; Sanjay Gupta
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

6.  Heparin recovers AT1 receptor and its intracellular signal transduction in cultured vascular smooth muscle cells.

Authors:  Tatsuo Hashimoto; Minoru Kihara; Keiko Sato; Nozomi Imai; Yutaka Tanaka; Masashi Sakai; Kouichi Tamura; Nobuhito Hirawa; Yoshiyuki Toya; Hitoshi Kitamura; Satoshi Umemura
Journal:  FEBS Lett       Date:  2005-01-03       Impact factor: 4.124

Review 7.  Immunosuppressive properties of mesenchymal stem cells.

Authors:  Mohamed Abumaree; Mohammed Al Jumah; Rishika A Pace; Bill Kalionis
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

8.  The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype.

Authors:  Jeffrey A Beamish; Leah C Geyer; Nada A Haq-Siddiqi; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Biomaterials       Date:  2009-08-26       Impact factor: 12.479

Review 9.  Animal models for vascular tissue-engineering.

Authors:  Daniel D Swartz; Stelios T Andreadis
Journal:  Curr Opin Biotechnol       Date:  2013-06-13       Impact factor: 9.740

10.  Highly Compliant Vascular Grafts with Gelatin-Sheathed Coaxially Structured Nanofibers.

Authors:  Naveen Nagiah; Richard Johnson; Roy Anderson; Winston Elliott; Wei Tan
Journal:  Langmuir       Date:  2015-11-19       Impact factor: 3.882

View more
  2 in total

Review 1.  Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies.

Authors:  Carsten W Lederer; Lola Koniali; Tina Buerki-Thurnherr; Panayiota L Papasavva; Stefania La Grutta; Amelia Licari; Frantisek Staud; Donato Bonifazi; Marina Kleanthous
Journal:  Pharmaceutics       Date:  2022-04-05       Impact factor: 6.525

Review 2.  Animal studies for the evaluation of in situ tissue-engineered vascular grafts - a systematic review, evidence map, and meta-analysis.

Authors:  Suzanne E Koch; Bente J de Kort; Noud Holshuijsen; Hannah F M Brouwer; Dewy C van der Valk; Patricia Y W Dankers; Judith A K R van Luijk; Carlijn R Hooijmans; Rob B M de Vries; Carlijn V C Bouten; Anthal I P M Smits
Journal:  NPJ Regen Med       Date:  2022-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.